Viral vectors remain the most efficient natural machines for crossing the cell membrane. Our work focuses on engineering the capsid surface to shift tropism toward target tissues while reducing recognition by pre-existing neutralising antibodies.
How we work on it
Every programme in this area follows the same staged path: target definition, carrier or formulation engineering, validation in physiologically relevant models, then transfer to continuous-flow GMP production. Read the full technology overview or talk to the team.